Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Salivary hypersecretion
ADR ID BADD_A03914
ADR Hierarchy
07      Gastrointestinal disorders
07.06      Salivary gland conditions
07.06.01      Oral dryness and saliva altered
07.06.01.009      Salivary hypersecretion
Description Increased salivary flow. [MeSH]
MedDRA Code 10039424
MeSH ID D012798; D012472
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hypersalivation | Increased salivation | Ptyalism | Saliva increased | Saliva secretion excessive | Saliva secretion increased | Salivary hypersecretion | Salivation | Sialorrhoea | Sialorrhea | Hypersialosis | Drooling
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01191Ipratropium0.000576%
BADD_D01195Irinotecan--
BADD_D01196Irinotecan hydrochloride--
BADD_D01203Isoflurane--
BADD_D01228Ketamine0.000308%
BADD_D01231Ketoprofen--
BADD_D01238Lacosamide0.013408%
BADD_D01243Lamotrigine0.001160%
BADD_D01245Lansoprazole--
BADD_D01253Lenalidomide--
BADD_D01265Levetiracetam0.001143%
BADD_D01275Levofloxacin0.000260%
BADD_D01285Levothyroxine0.000023%
BADD_D01300Lisinopril--
BADD_D01303Lithium carbonate--
BADD_D01304Lithium cation--
BADD_D01305Lithium hydroxide--
BADD_D01317Loratadine--
BADD_D01318Lorazepam--
BADD_D01326Loxapine--
BADD_D01327Loxapine succinate--
BADD_D01330Lurasidone0.001592%
BADD_D01331Lurasidone hydrochloride--
BADD_D01336Macitentan--
BADD_D01345Magnevist--
BADD_D01350Maprotiline--
BADD_D01351Maprotiline hydrochloride--
BADD_D01371Megestrol--
BADD_D01372Megestrol acetate--
BADD_D01373Melatonin--
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 9 Pages